[
  {
    "date": "2023-12-30",
    "symbol": "KURA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KURA",
    "entityregistrantname": "KURA ONCOLOGY, INC.",
    "entitycentralindexkey": 1422143,
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-37620",
    "entitytaxidentificationnumber": "61-1547851",
    "entityaddressaddressline1": "12730 High Bluff Drive",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "500-8800",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "San Diego, CA USA",
    "cashandcashequivalentsatcarryingvalue": 37318000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 386639000,
    "prepaidexpenseandotherassetscurrent": 8524000,
    "assetscurrent": 432481000,
    "propertyplantandequipmentnet": 1859000,
    "operatingleaserightofuseasset": 6993000,
    "otherassetsnoncurrent": 7602000,
    "assets": 448935000,
    "accountspayableandaccruedliabilitiescurrent": 33757000,
    "operatingleaseliabilitycurrent": 1506000,
    "liabilitiescurrent": 35263000,
    "longtermdebtnoncurrent": 9332000,
    "operatingleaseliabilitynoncurrent": 6362000,
    "otherliabilitiesnoncurrent": 705000,
    "liabilities": 51662000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 1119976000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1271000,
    "retainedearningsaccumulateddeficit": -721439000,
    "stockholdersequity": 397273000,
    "liabilitiesandstockholdersequity": 448935000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 74350000,
    "commonstocksharesoutstanding": 74350000,
    "researchanddevelopmentexpense": 115235000,
    "generalandadministrativeexpense": 50569000,
    "operatingexpenses": 165804000,
    "interestandotherincome": 14722000,
    "interestexpense": 1549000,
    "nonoperatingincomeexpense": 13173000,
    "netincomeloss": -152631000,
    "earningspersharediluted": -2.08,
    "earningspersharebasic": -2.08,
    "weightedaveragenumberofsharesoutstandingbasic": 73229000,
    "weightedaveragenumberofdilutedsharesoutstanding": 73229000,
    "unrealizedgainlossonmarketablesecuritiesandforeigncurrency": 6761000,
    "comprehensiveincomenetoftax": -145870000,
    "sharesoutstanding": 74350000,
    "stockissuedduringperiodvaluenewissues": 60919000,
    "stockissuedduringperiodsharesnewissues": 5661000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 28082000,
    "stockissuedduringperiodvaluesharebasedcompensation": 1206000,
    "stockissuedduringperiodsharessharebasedcompensation": 375000,
    "issuanceofprefundedwarrantstopurchasecommonstocknetofofferingcosts": 32658000,
    "othercomprehensiveincomelossnetoftax": 6761000,
    "sharebasedcompensation": 28082000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 9420000,
    "depreciation": 849000,
    "amortizationoffinancingcosts": 477000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1960000,
    "increasedecreaseinoperatingleaserightofuseassetsandothernoncurrentassets": 685000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 10327000,
    "increasedecreaseinothernoncurrentliabilities": 137000,
    "netcashprovidedbyusedinoperatingactivities": -124824000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 425549000,
    "paymentstoacquiremarketablesecurities": 409824000,
    "paymentstoacquirepropertyplantandequipment": 168000,
    "netcashprovidedbyusedininvestingactivities": 15557000,
    "proceedsfromissuanceofcommonstockandprefundedwarrantsnetofofferingcosts": 93577000,
    "proceedsfromstockplans": 1206000,
    "netcashprovidedbyusedinfinancingactivities": 94783000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -14484000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 37318000,
    "interestpaidnet": 1064000,
    "restrictedcashnoncurrent": 200000,
    "restrictedcashnoncurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "numberofoperatingsegments": 1,
    "employeeretentioncreditrecognizedduringperiod": 2800000,
    "employeeretentioncreditreceivableduringperiod": 2800000,
    "propertyplantandequipmentusefullife": "P3Y",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaseoptiontoterminate": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 12642000,
    "cashequivalentmaturityterm": "P1Y",
    "cashequivalentsatcarryingvalue": 13590000,
    "cashequivalentsfairvaluedisclosure": 13590000,
    "debtsecuritiesavailableforsaleterm": "P2Y",
    "availableforsaledebtsecuritiesamortizedcostbasis": 300388000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 395000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 569000,
    "cashequivalentsandshortterminvestmentsamortizedcost": 401500000,
    "cashequivalentsandshortterminvestmentsunrealizedgains": 399000,
    "cashequivalentsandshortterminvestmentsunrealizedlosses": 1670000,
    "cashequivalentsandshortterminvestmentsfairvalue": 400229000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 336600000,
    "availableforsalesecuritiesdebtmaturitiesonetotwoyears": 50000000,
    "shortterminvestmentsmaturitiesdescription": "As of December 31, 2023 and 2022, short-term investments of $336.6 million and $274.3 million, respectively, had maturities less than one year, and short-term investments of $50.0 million and $111.9 million, respectively, had maturities between one to two years.",
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 16,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 155200000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 105000000,
    "interestreceivable": 1100000,
    "cashandcashequivalentsfairvaluedisclosure": 13590000,
    "cashequivalentsandshortterminvestments": 400229000,
    "propertyplantandequipmentgross": 1657000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2452000,
    "accountspayablecurrent": 2300000,
    "accruedclinicaltrialresearchanddevelopmentexpensescurrent": 7737000,
    "accruedotherresearchanddevelopmentexpenses": 9265000,
    "employeerelatedliabilitiescurrent": 13153000,
    "otheraccruedliabilitiescurrent": 1302000,
    "lineofcreditfacilitymaximumborrowingcapacity": 35000000,
    "debtinstrumentfaceamount": 10000000,
    "termloantranchetwoavailabilityenddate": "2024-03-15",
    "debtinstrumentdateoffirstrequiredpayment1": "2025-05-01",
    "debtinstrumentmaturitydaterangestart1": "2025-11-01",
    "debtinstrumentinterestrateterms": "The per annum interest rate for the Term Loans is the greater of (i) the prime rate as reported in The Wall Street Journal minus 6.25% plus 8.65% and (ii) 8.65%.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 14.38,
    "debtinstrumentmaturitydate": "2027-11-02",
    "debtinstrumentinterestratestatedpercentage": 0.109,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 2307000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 3798000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 3895000,
    "debtinstrumentunamortizeddiscount": 668000,
    "contingentmilestonepayables": 80200000,
    "contingentmilestonepaid": 300000,
    "numberofoperatingleases": 3,
    "lesseeoperatingleaseexpirationperiod": "We currently have three operating leases for administrative and research and development office and lab space in San Diego, California and Boston, Massachusetts that expire between July 2024 and July 2031.",
    "numberofleasesthatincluderenewaloption": 2,
    "lesseeoperatingleaserenewalterm": "P5Y",
    "reimbursementsfortenantimprovements": 1000000,
    "lettersofcreditoutstandingamount": 200000,
    "operatingleaseweightedaveragediscountratepercent": 0.104,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y2M12D",
    "operatingleasepayments": 2100000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 4700000,
    "operatingleaseexpense": 2000000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1545000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1964000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1344000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1371000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1398000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 3740000,
    "lesseeoperatingleaseliabilitypaymentsdue": 11362000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3494000,
    "operatingleaseliability": 7868000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 26078,
    "increaseinpercentageofsharesofcommonstockavailableforfuturegrants": 0.01,
    "commonstockmaximumnumberofsharesissuable": 2000000,
    "automaticincreaseinpercentageofsharesofcommonstockavailableforfuturegrant": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 24327686,
    "commonstockcapitalsharesreservedforfutureissuance": 3713092,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "closingstockprice": 14.38,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 37100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 9100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "stockpurchaseplanofferingperiodterm": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 250573,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 528000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10297000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2857000,
    "stockissuedduringperiodsharesstockoptionsexercised": 83000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 902000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 10297000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5962000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 16.46,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 11.74,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 18.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 16.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 17.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 12883000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 12883000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 6000000,
    "proceedsfromstockoptionsexercised": 534000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 280000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 956000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsreleasedinperiod": 218000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 122000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardotherthanoptionsvestedandexpectedtovestoutstandingnumber": 956000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 14.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsreleasedinperiodweightedaveragegrantdatefairvalue": 16.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 14.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestedweightedaveragegrantdatefairvaluepershare": 14.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingvestingperiod": "P1Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestweightedaverageremainingvestingperiod": "P1Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 13748000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 13748000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y5M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.599,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.669,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.054,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.047,
    "researchanddevelopmentservicesreimbursementdescription": "In addition, the agreement allows for Araxes to reimburse us an amount equal to the number of full-time equivalents performing research and development services for Araxes, plus actual expenses as reasonably incurred.",
    "managementfeeincomerelatedparty": 100000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.04,
    "definedcontributionplancostrecognized": 1500000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 457300000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2034,
    "taxcreditcarryforwardamount": 35100000,
    "taxcreditcarryforwardbeginningexpirationyear": 2034,
    "researchanddevelopmenttaxcreditcarryforwardexpire": 2031,
    "taxcreditcarryforwardsnotsubjecttoexpiration": 3700000,
    "taxcreditcarryforwardssubjecttoexpiration": 4000000,
    "valuationallowancedeferredtaxassetchangeinamount": 47900000,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "An uncertain tax position will not be recognized if it has less than a 50% likelihood of being sustained.",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -32053000,
    "incometaxreconciliationstateandlocalincometaxes": -11027000,
    "incometaxreconciliationtaxcreditsresearch": 10551000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 4125000,
    "incometaxreconciliationotheradjustments": -332000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 49838000,
    "deferredtaxassetsoperatinglosscarryforwards": 144451000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 31816000,
    "deferredtaxassetstaxcreditcarryforwardssection174capitalization": 33947000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8946000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 3396000,
    "deferredtaxassetstaxdeferredexpenseoperatingleaseliabilities": 2311000,
    "deferredtaxassetsother": 1139000,
    "deferredtaxassetsothercomprehensiveloss": 373000,
    "deferredtaxassetsgross": 226379000,
    "deferredincometaxliabilities": 2198000,
    "deferredtaxassetsvaluationallowance": 224181000,
    "unrecognizedtaxbenefits": 10114000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 82000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 3547000
  },
  {
    "date": "2022-12-30",
    "symbol": "KURA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KURA",
    "entityregistrantname": "KURA ONCOLOGY, INC.",
    "entitycentralindexkey": 1422143,
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-37620",
    "entitytaxidentificationnumber": "61-1547851",
    "entityaddressaddressline1": "12730 High Bluff Drive",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "500-8800",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "San Diego, CA USA",
    "cashandcashequivalentsatcarryingvalue": 51802000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 206134000,
    "prepaidexpenseandotherassetscurrent": 8441000,
    "assetscurrent": 446426000,
    "propertyplantandequipmentnet": 2540000,
    "restrictedcashnoncurrent": 210000,
    "operatingleaserightofuseasset": 3842000,
    "otherassetsnoncurrent": 3288000,
    "assets": 456306000,
    "accountspayableandaccruedliabilitiescurrent": 21739000,
    "operatingleaseliabilitycurrent": 2318000,
    "liabilitiescurrent": 24057000,
    "longtermdebtnoncurrent": 9158000,
    "operatingleaseliabilitynoncurrent": 2548000,
    "otherliabilitiesnoncurrent": 265000,
    "liabilities": 36028000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 997111000,
    "accumulatedothercomprehensiveincomelossnetoftax": -8032000,
    "retainedearningsaccumulateddeficit": -568808000,
    "stockholdersequity": -568808000,
    "liabilitiesandstockholdersequity": 456306000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 68314000,
    "commonstocksharesoutstanding": 68314000,
    "researchanddevelopmentexpense": 92812000,
    "generalandadministrativeexpense": 47053000,
    "operatingexpenses": 139865000,
    "interestandotherincome": 4254000,
    "interestexpense": 229000,
    "nonoperatingincomeexpense": 4025000,
    "netincomeloss": -135840000,
    "earningspersharediluted": -2.03,
    "earningspersharebasic": -2.03,
    "weightedaveragenumberofsharesoutstandingbasic": 66990000,
    "weightedaveragenumberofdilutedsharesoutstanding": 66990000,
    "unrealizedgainlossonmarketablesecuritiesandforeigncurrency": -6243000,
    "comprehensiveincomenetoftax": -142083000,
    "sharesoutstanding": 68314000,
    "stockissuedduringperiodvaluenewissues": 24721000,
    "stockissuedduringperiodsharesnewissues": 1370000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 26318000,
    "stockissuedduringperiodvaluesharebasedcompensation": 4419000,
    "stockissuedduringperiodsharessharebasedcompensation": 372000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 294000,
    "othercomprehensiveincomelossnetoftax": -6243000,
    "sharebasedcompensation": 15945000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -1610000,
    "depreciation": 759000,
    "paidinkindinterest": 73000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2935000,
    "increasedecreaseinoperatingleaserightofuseassetsandothernoncurrentassets": -571000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -802000,
    "increasedecreaseinothernoncurrentliabilities": 184000,
    "netcashprovidedbyusedinoperatingactivities": -110062000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 303908000,
    "paymentstoacquiremarketablesecurities": 270655000,
    "paymentstoacquirepropertyplantandequipment": 626000,
    "netcashprovidedbyusedininvestingactivities": 32627000,
    "proceedsfromissuanceofcommonstock": 24721000,
    "proceedsfromstockplans": 4419000,
    "proceedsfromissuanceoflongtermdebt": 10000000,
    "paymentsofdebtissuancecosts": 575000,
    "netcashprovidedbyusedinfinancingactivities": 38565000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -38870000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 52012000,
    "interestpaidnet": 73000,
    "warrantsissuedinconnectionwithdebtfacility": 294000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 210000,
    "propertyplantandequipmentusefullife": "five years",
    "lesseeoperatingleaseexistenceofoptiontoextend": "extend",
    "lesseeoperatingleaseoptiontoextend": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "terminate",
    "lesseeoperatingleaseoptiontoterminate": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "cashequivalentmaturitydescription": 1,
    "cashequivalentsatcarryingvalue": 47834000,
    "cashequivalentsfairvaluedisclosure": 47834000,
    "debtsecuritiesavailableforsaleterm": 1,
    "availableforsaledebtsecuritiesamortizedcostbasis": 394215000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 27000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 8059000,
    "cashequivalentsandshortterminvestmentsamortizedcost": 442049000,
    "cashequivalentsandshortterminvestmentsunrealizedlosses": 8059000,
    "cashequivalentsandshortterminvestmentsfairvalue": 434017000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 274300000,
    "availableforsalesecuritiesdebtmaturitiesonetothreeyears": 111900000,
    "shortterminvestmentsmaturitiesdescription": "As of December 31, 2022 and 2021, short-term investments of $274.3 million and $246.9 million, respectively, had maturities less than one year, and short-term investments of $111.9 million and $180.4 million, respectively, had maturities between one to three years.",
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 34,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 290000000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 172400000,
    "interestreceivable": 900000,
    "cashandcashequivalentsfairvaluedisclosure": 9956000,
    "cashequivalentsandshortterminvestments": 216090000,
    "propertyplantandequipmentgross": 4143000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1603000,
    "accountspayablecurrent": 1533000,
    "accruedclinicaltrialresearchanddevelopmentexpensescurrent": 2440000,
    "accruedotherresearchanddevelopmentexpenses": 5030000,
    "employeerelatedliabilitiescurrent": 10300000,
    "otheraccruedliabilitiescurrent": 2436000,
    "debtinstrumentfaceamount": 10000000,
    "debtinstrumentdateoffirstrequiredpayment1": "November 1, 2024",
    "debtinstrumentmaturitydaterangestart1": "November 1, 2026",
    "debtinstrumentinterestrateterms": "The per annum interest rate for the Term Loans is the greater of (i) the prime rate as reported in The Wall Street Journal minus 6.25% plus 8.65% and (ii) 8.65%.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.31,
    "debtinstrumentpaymentterms": "The SVB Term Loan had a scheduled maturity date of May 1, 2023.",
    "debtinstrumentmaturitydate": "November 2, 2027",
    "debtinstrumentinterestrateeffectivepercentage": 0.099,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 464000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 2953000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 3263000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 3320000,
    "debtinstrumentunamortizeddiscount": 842000,
    "contingentmilestonepaid": 200000,
    "numberofoperatingleases": 3,
    "lesseeoperatingleaseexpirationperiod": "We currently have three operating leases for administrative and research and development office and lab space in San Diego, California and Boston, Massachusetts that expire between July 2024 and November 2025.",
    "numberofleasesthatincluderenewaloption": 2,
    "lesseeoperatingleaserenewalterm": "five years",
    "reimbursementsfortenantimprovements": 100000,
    "lettersofcreditoutstandingamount": 200000,
    "operatingleaseweightedaveragediscountratepercent": 0.055,
    "operatingleaseweightedaverageremainingleaseterm1": 2.3,
    "operatingleasepayments": 2300000,
    "operatingleaseexpense": 2000000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2375000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1863000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 929000,
    "lesseeoperatingleaseliabilitypaymentsdue": 5167000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 301000,
    "operatingleaseliability": 4866000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 33988,
    "increaseinpercentageofsharesofcommonstockavailableforfuturegrants": 0.01,
    "commonstockmaximumnumberofsharesissuable": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "commonstockcapitalsharesreservedforfutureissuance": 727433,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "shareprice": 12.41,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 44700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 9800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.4,
    "employeestockpurchaseplanofferingperiodterm": " six-month",
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8425000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2904000,
    "stockissuedduringperiodsharesstockoptionsexercised": 265000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1165000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8425000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4412000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 18.12,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 14.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 21.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 18.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 17.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3082000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3082000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2860000,
    "proceedsfromstockoptionsexercised": 3756000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 701000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 768000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 746000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsreleasedinperiod": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 99000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardotherthanoptionsvestedandexpectedtovestoutstandingnumber": 768000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 16.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 13.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsreleasedinperiodweightedaveragegrantdatefairvalue": 32.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 17.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestedweightedaveragegrantdatefairvaluepershare": 16.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestweightedaverageremainingvestingperiod": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 9541000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 9541000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.758,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.046,
    "subleaseterm": "We subleased office space in San Diego, California from Araxes between June 2017 and June 2020.",
    "researchanddevelopmentservicesreimbursementdescription": "In addition, the agreement allows for Araxes to reimburse us an amount equal to the number of full-time equivalents, or FTE, performing research and development services for Araxes, plus actual expenses as reasonably incurred. ",
    "managementfeeincomerelatedparty": 100000,
    "paymentofresearchanddevelopmentexpensedescription": "We have a services agreement with Wellspring Biosciences, Inc., or Wellspring, a wholly-owned subsidiary of Araxes, pursuant to which we pay Wellspring for research and development services provided to us in an amount equal to the number of FTEâ€™s performing the services, at an annual FTE rate of $400,000, plus actual expenses as reasonably incurred. For the years ended December 31, 2022 and 2021, we did not recognize any expense under this service agreement. ",
    "definedcontributionplanemployermatchingcontributionpercent": 0.04,
    "definedcontributionplancostrecognized": 1200000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 572000000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2034,
    "operatinglosscarryforwardsmaturitydate": 2030,
    "taxcreditcarryforwardamount": 5400000,
    "taxcreditcarryforwardbeginningexpirationyear": 2034,
    "researchanddevelopmenttaxcreditcarryforwardexpire": 2031,
    "taxcreditcarryforwardsnotsubjecttoexpiration": 3000000,
    "taxcreditcarryforwardssubjecttoexpiration": 2400000,
    "valuationallowancedeferredtaxassetchangeinamount": 43100000,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "An uncertain tax position will not be recognized if it has less than a 50% likelihood of being sustained.",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -28526000,
    "incometaxreconciliationstateandlocalincometaxes": -9721000,
    "incometaxreconciliationtaxcreditsresearch": 6970000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 3998000,
    "incometaxreconciliationotheradjustments": -69000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 41288000,
    "deferredtaxassetsoperatinglosscarryforwards": 125986000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 20876000,
    "deferredtaxassetstaxcreditcarryforwardssection174capitalization": 16684000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 6599000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 2713000,
    "deferredtaxassetsothercomprehensiveloss": 2360000,
    "deferredtaxassetstaxdeferredexpenseoperatingleaseliabilities": 1430000,
    "deferredtaxassetsother": 1018000,
    "deferredtaxassetsgross": 177666000,
    "deferredtaxassetsvaluationallowance": 176328000,
    "deferredtaxassetsnet": 1338000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 1129000,
    "deferredtaxliabilitiesother": 209000,
    "deferredincometaxliabilities": 1338000,
    "unrecognizedtaxbenefits": 6485000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 67000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 2016000
  },
  {
    "date": "2021-12-30",
    "symbol": "KURA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KURA",
    "entityregistrantname": "KURA ONCOLOGY, INC.",
    "entitycentralindexkey": 1422143,
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-37620",
    "entitytaxidentificationnumber": "61-1547851",
    "entityaddressaddressline1": "12730 High Bluff Drive",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "500-8800",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "New York, NY USA",
    "cashandcashequivalentsatcarryingvalue": 90672000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 292455000,
    "prepaidexpenseandotherassetscurrent": 4329000,
    "assetscurrent": 522289000,
    "propertyplantandequipmentnet": 2673000,
    "restrictedcashnoncurrent": 210000,
    "operatingleaserightofuseasset": 5573000,
    "otherassetsnoncurrent": 3306000,
    "assets": 534051000,
    "accountspayableandaccruedliabilitiescurrent": 22455000,
    "liabilitiescurrent": 22455000,
    "operatingleaseliabilitynoncurrent": 4612000,
    "otherliabilitiesnoncurrent": 375000,
    "liabilities": 27442000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 941359000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1789000,
    "retainedearningsaccumulateddeficit": -432968000,
    "stockholdersequity": -432968000,
    "liabilitiesandstockholdersequity": 534051000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 66572000,
    "commonstocksharesoutstanding": 66572000,
    "researchanddevelopmentexpense": 84721000,
    "generalandadministrativeexpense": 46537000,
    "operatingexpenses": 131258000,
    "interestandotherincome": 1206000,
    "interestexpense": 414000,
    "nonoperatingincomeexpense": 792000,
    "netincomeloss": -130466000,
    "earningspersharebasicanddiluted": -1.97,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 66352000,
    "unrealizedgainlossonmarketablesecuritiesandforeigncurrency": -1835000,
    "comprehensiveincomenetoftax": -132301000,
    "sharesoutstanding": 66572000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 23579000,
    "issuanceofcommonstockfromexerciseofoptionsandemployeestockpurchaseplan": 4426000,
    "issuanceofcommonstocksharesfromexerciseofoptionsandemployeestockpurchaseplan": 378000,
    "othercomprehensiveincomelossnetoftax": -1835000,
    "sharebasedcompensation": 16125000,
    "paidinkindinterest": 399000,
    "gainslossesonextinguishmentofdebt": -212000,
    "depreciation": 558000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -4391000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 357000,
    "increasedecreaseinothernoncurrentassets": 329000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -2518000,
    "increasedecreaseinothernoncurrentliabilities": -20000,
    "netcashprovidedbyusedinoperatingactivities": -104551000,
    "paymentstoacquiremarketablesecurities": 445657000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 319969000,
    "paymentstoacquirepropertyplantandequipment": 1147000,
    "netcashprovidedbyusedininvestingactivities": -126835000,
    "repaymentsoflongtermdebt": 7250000,
    "paymentsofdebtextinguishmentcosts": 611000,
    "proceedsfromexerciseofstockoptionsandpurchasesunderemployeestockpurchaseplan": 4426000,
    "netcashprovidedbyusedinfinancingactivities": -3435000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -234821000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 90882000,
    "interestpaidnet": 784000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 210000,
    "propertyplantandequipmentusefullife": "five years",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaseoptiontoterminate": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "cashequivalentmaturitydescription": "1 or less",
    "cashequivalentsatcarryingvalue": 79895000,
    "cashequivalentsfairvaluedisclosure": 79895000,
    "debtsecuritiesavailableforsaleterm": 2,
    "availableforsaledebtsecuritiesamortizedcostbasis": 429071000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1783000,
    "cashequivalentsandshortterminvestmentsamortizedcost": 508966000,
    "cashequivalentsandshortterminvestmentsunrealizedlosses": 1783000,
    "cashequivalentsandshortterminvestmentsfairvalue": 507183000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 246900000,
    "availableforsalesecuritiesdebtmaturitiesonetothreeyears": 180400000,
    "shortterminvestmentsmaturitiesdescription": "As of December 31, 2021 and 2020, short-term investments of $246.9 million and $242.6 million, respectively, had maturities less than one year, and short-term investments of $180.4 million and $65.2 million, respectively, had maturities between one to three years.",
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongernumberofpositions": 36,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 373900000,
    "interestreceivable": 1400000,
    "cashandcashequivalentsfairvaluedisclosure": 79895000,
    "cashequivalentsandshortterminvestments": 292455000,
    "propertyplantandequipmentgross": 3517000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 844000,
    "accountspayablecurrent": 3236000,
    "accruedclinicaltrialresearchanddevelopmentexpensescurrent": 2619000,
    "accruedotherresearchanddevelopmentexpenses": 5341000,
    "employeerelatedliabilitiescurrent": 7923000,
    "operatingleaseliabilitycurrent": 2263000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndAccruedLiabilitiesCurrent",
    "otheraccruedliabilitiescurrent": 1073000,
    "debtinstrumentpaymentterms": "The Term Loan had a scheduled maturity date of May 1, 2023.",
    "debtinstrumentmaturitydate": "May 1, 2023",
    "contingentmilestonepaid": 100000,
    "numberofoperatingleases": 3,
    "lesseeoperatingleaseexpirationperiod": "We currently have three operating leases for administrative and research and development office and lab space in San Diego, California and Boston, Massachusetts that expire between July 2024 and November 2025.",
    "numberofleasesthatincluderenewaloption": 2,
    "lesseeoperatingleaserenewalterm": "five years",
    "tenantimprovements": 100000,
    "operatingleaseliability": 6875000,
    "lettersofcreditoutstandingamount": 200000,
    "operatingleaseweightedaveragediscountratepercent": 0.055,
    "operatingleaseweightedaverageremainingleaseterm1": 3.3,
    "operatingleasepayments": 2100000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1000000,
    "operatingleaseexpense": 2000000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2319000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2375000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1863000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 929000,
    "lesseeoperatingleaseliabilitypaymentsdue": 7486000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 611000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 33988,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.31,
    "increaseinpercentageofsharesofcommonstockavailableforfuturegrants": 0.01,
    "commonstockmaximumnumberofsharesissuable": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "commonstockcapitalsharesreservedforfutureissuance": 128006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "shareprice": 14,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 52300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 4099999.9999999995,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.1,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 110699,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6951000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2835000,
    "stockissuedduringperiodsharesstockoptionsexercised": 343000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 562000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6951000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3145000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 20.08,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 27.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 11.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 21.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 20.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 16.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5565000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 5565000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 4152000,
    "proceedsfromstockoptionsexercised": 3809000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 3475000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 17.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 161,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 187,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardotherthanoptionsvestedandexpectedtovestoutstandingnumber": 161,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 32.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 32.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 32.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestedweightedaveragegrantdatefairvaluepershare": 32.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestweightedaverageremainingvestingperiod": 1.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 2261000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 2261000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.44799999999999995,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.618,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.001,
    "subleaseterm": "We subleased office space in San Diego, California from Araxes between June 2017 and June 2020.",
    "researchanddevelopmentservicesreimbursementdescription": "In addition, the agreement allows for Araxes to reimburse us an amount equal to the number of full-time equivalents, or FTE, performing research and development services for Araxes, at an annual FTE rate of approximately $382,000, plus actual expenses as reasonably incurred. ",
    "managementfeeincomerelatedparty": 100000,
    "paymentofresearchanddevelopmentexpensedescription": "We have a services agreement with Wellspring Biosciences, Inc., or Wellspring, a wholly-owned subsidiary of Araxes, pursuant to which we pay Wellspring for research and development services provided to us in an amount equal to the number of FTEâ€™s performing the services, at an annual FTE rate of $400,000, plus actual expenses as reasonably incurred. For the year ended December 31, 2021, we did not recognize any expense under this service agreement. ",
    "milestonepaymentspaidtodate": 300000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.04,
    "definedcontributionplancostrecognized": 1000000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 500000,
    "operatinglosscarryforwardsbeginningexpirationyear": 2034,
    "operatinglosscarryforwardsmaturitydate": 2030,
    "taxcreditcarryforwardamount": 4000000,
    "taxcreditcarryforwardbeginningexpirationyear": 2034,
    "researchanddevelopmenttaxcreditcarryforwardexpire": 2031,
    "taxcreditcarryforwardsnotsubjecttoexpiration": 2400000,
    "taxcreditcarryforwardssubjecttoexpiration": 1600000,
    "valuationallowancedeferredtaxassetchangeinamount": 40700000,
    "deferredtaxassetsvaluationallowance": 133206000,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "An uncertain tax position will not be recognized if it has less than a 50% likelihood of being sustained.",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -27398000,
    "incometaxreconciliationstateandlocalincometaxes": -9758000,
    "incometaxreconciliationtaxcreditsresearch": 5850000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 2819000,
    "incometaxreconciliationotheradjustments": -496000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 40683000,
    "deferredtaxassetsoperatinglosscarryforwards": 111238000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 13794000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4842000,
    "deferredtaxassetstaxdeferredexpenseoperatingleaseliabilities": 2021000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 2096000,
    "deferredtaxassetsother": 1088000,
    "deferredtaxassetsgross": 135079000,
    "deferredtaxassetsnet": 1873000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 1638000,
    "deferredtaxliabilitiesother": 235000,
    "deferredincometaxliabilities": 1873000,
    "unrecognizedtaxbenefits": 4402000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1424000
  },
  {
    "date": "2020-12-30",
    "symbol": "KURA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "DecemberÂ 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KURA",
    "entityregistrantname": "KURA ONCOLOGY, INC.",
    "entitycentralindexkey": 1422143,
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "LargeÂ acceleratedÂ filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-37620",
    "entitytaxidentificationnumber": "61-1547851",
    "entityaddressaddressline1": "12730 High Bluff Drive",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "500-8800",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "cashandcashequivalentsatcarryingvalue": 325493000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 219370000,
    "prepaidexpenseandotherassetscurrent": 3972000,
    "assetscurrent": 637292000,
    "propertyplantandequipmentnet": 2021000,
    "restrictedcashnoncurrent": 210000,
    "operatingleaserightofuseasset": 6334000,
    "otherassetsnoncurrent": 1355000,
    "assets": 647212000,
    "accountspayableandaccruedliabilitiescurrent": 23024000,
    "longtermdebtcurrent": 3000000,
    "liabilitiescurrent": 26024000,
    "longtermdebtnoncurrent": 4250000,
    "operatingleaseliabilitynoncurrent": 5638000,
    "otherliabilitiesnoncurrent": 395000,
    "liabilities": 36307000,
    "commonstockvalue": 7000,
    "additionalpaidincapitalcommonstock": 913354000,
    "accumulatedothercomprehensiveincomelossnetoftax": 46000,
    "retainedearningsaccumulateddeficit": -302502000,
    "stockholdersequity": -302502000,
    "liabilitiesandstockholdersequity": 647212000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 66194000,
    "commonstocksharesoutstanding": 66194000,
    "researchanddevelopmentexpense": 60397000,
    "generalandadministrativeexpense": 31502000,
    "operatingexpenses": 91899000,
    "managementfeeincomerelatedparty": 100000,
    "interestandotherincome": 2801000,
    "interestexpense": 578000,
    "nonoperatingincomeexpense": 2274000,
    "netincomeloss": -89625000,
    "earningspersharebasicanddiluted": -1.69,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 53077000,
    "unrealizedgainlossonmarketablesecuritiesandforeigncurrency": -285000,
    "comprehensiveincomenetoftax": -89910000,
    "relatedpartytransactionresearchanddevelopmentexpense": 100000,
    "relatedpartytransactiongeneralandadministrativeexpenses": 188000,
    "sharesoutstanding": 66194000,
    "stockissuedduringperiodvaluenewissues": 458978000,
    "stockissuedduringperiodsharesnewissues": 19792000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 12807000,
    "issuanceofcommonstockfromexerciseofoptionsandemployeestockpurchaseplan": 10249000,
    "issuanceofcommonstocksharesfromexerciseofoptionsandemployeestockpurchaseplan": 1018000,
    "othercomprehensiveincomelossnetoftax": -285000,
    "sharebasedcompensation": 246000,
    "depreciation": 194000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -410000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 711000,
    "increasedecreaseinothernoncurrentassets": -1205000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 5677000,
    "increasedecreaseinothernoncurrentliabilities": 213000,
    "netcashprovidedbyusedinoperatingactivities": -69830000,
    "paymentstoacquiremarketablesecurities": 320963000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 223198000,
    "paymentstoacquirepropertyplantandequipment": 2171000,
    "netcashprovidedbyusedininvestingactivities": -99936000,
    "proceedsfromissuanceofcommonstock": 459335000,
    "proceedsfromexerciseofstockoptionsandpurchasesunderemployeestockpurchaseplan": 10249000,
    "repaymentsoflongtermdebt": 250000,
    "netcashprovidedbyusedinfinancingactivities": 469334000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 299568000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 325703000,
    "interestpaidnet": 419000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 210000,
    "propertyplantandequipmentusefullife": "five years",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaseoptiontoterminate": "Lease terms may include options to extend or terminate when we are reasonably certain that the options will be exercised.",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "cashequivalentmaturitydescription": "1 or less",
    "cashequivalentsatcarryingvalue": 317237000,
    "cashequivalentsfairvaluedisclosure": 5998000,
    "availableforsalesecuritiesmaturitydescription": "1 or less",
    "availableforsaledebtsecuritiesamortizedcostbasis": 307779000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 86000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 38000,
    "cashequivalentsandshortterminvestmentsamortizedcost": 625016000,
    "cashequivalentsandshortterminvestmentsunrealizedgains": 86000,
    "cashequivalentsandshortterminvestmentsunrealizedlosses": 38000,
    "cashequivalentsandshortterminvestmentsfairvalue": 625064000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 242600000,
    "availableforsalesecuritiesdebtmaturitiesonetotwoyears": 65200000,
    "shortterminvestmentsmaturitiesdescription": "As of DecemberÂ 31, 2020 and 2019, short-term investments of $242.6 million and $196.1 million, respectively, had maturities less than one year, and short-term investments of $65.2 million and $14.7 million, respectively, had maturities between one to two years.",
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 85200000,
    "availableforsalesecuritiesinunrealizedlosspositionsqualitativedisclosurenumberofpositions1": 10,
    "cashequivalentsandshortterminvestments": 225368000,
    "propertyplantandequipmentgross": 2307000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 286000,
    "accountspayablecurrent": 2753000,
    "accruedclinicaltrialresearchanddevelopmentexpensescurrent": 4080000,
    "accruedotherresearchanddevelopmentexpenses": 5581000,
    "employeerelatedliabilitiescurrent": 7016000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "kura:OperatingLeaseLiabilityCurrentMember",
    "operatingleaseliabilitycurrent": 2089000,
    "otheraccruedliabilitiescurrent": 1505000,
    "debtinstrumentcarryingamount": 7250000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 33988,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.31,
    "additionalborrowingdescription": "Under the terms of the SVB Loan Agreement, we could, at our sole discretion, borrow from the Lender up to an additional $12.5 million by a specified date. The draw period for the additional loan expired without us drawing down the additional loan.Â ",
    "debtinstrumentmaturitydate": "May 1, 2023",
    "debtinstrumentpaymentterms": "The Term Loan is due on the scheduled maturity date of May 1, 2023, or Maturity Date. Repayment of the Term Loan was interest only through NovemberÂ 30, 2020, followed by 30 equal monthly payments of principal plus accrued interest which commenced on December 1, 2020.",
    "debtinstrumentnumberofequalmonthlypaymentsofprincipalandaccruedinterest": 30,
    "debtinstrumentfrequencyofperiodicpayment": "monthly",
    "debtinstrumentdateoffirstrequiredpayment1": "December 1, 2020",
    "debtinstrumentbasisspreadonvariablerate1": 0.0025,
    "debtinstrumentinterestratestatedpercentage": 0.055,
    "finalpaymentasapercentageofamountsborrowed": 0.0775,
    "debtinstrumentinterestratebasisforeffectiverate": "The per annum interest rate for the outstanding Term Loan is the greater of (i)Â 5.50% and (ii)Â the sum of (a)Â the prime rate reported in The Wall Street Journal plus (b)Â 0.25%.",
    "lineofcreditfacilityprepaymentfeepercentageonoutstandingprincipalamount": 0.01,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 3328000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 3160000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 1849000,
    "debtinstrumentfaceamount": 8337000,
    "interestpayablecurrentandnoncurrent": 1087000,
    "contingentmilestonepaid": 100000,
    "subleaseexpirationdate": "2020-06-30",
    "operatingleaseliability": 7727000,
    "operatingleaseweightedaveragediscountratepercent": 0.055,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y1M6D",
    "operatingleasepayments": 300000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 7500000,
    "operatingleasesrentexpensenet": 200000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2141000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2098000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2080000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1558000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 722000,
    "lesseeoperatingleaseliabilitypaymentsdue": 8599000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 872000,
    "sharesissuedpricepershare": 37,
    "increaseinpercentageofsharesofcommonstockavailableforfuturegrants": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "commonstockcapitalsharesreservedforfutureissuance": 163051,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "shareprice": 32.66,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 30900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 500000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 75654,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5021000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2549000,
    "stockissuedduringperiodsharesstockoptionsexercised": 982000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 626000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 5021000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1848000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 15.37,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 15.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.94,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 15.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 13.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 87172000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 87172000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 34979000,
    "proceedsfromstockoptionsexercised": 9766000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 13348000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.553,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.919,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.009,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 13.35,
    "paymentofresearchanddevelopmentexpensedescription": "We had a services agreement with ALG Partners, Inc., or ALG Partners, a recruiting and temporary staffing agency. Our chief operating officer is an immediate family member of the president of ALG Partners.",
    "milestonepaymentspaidtodate": 300000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "definedcontributionplancostrecognized": 600000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 500000,
    "operatinglosscarryforwardsmaturitydate": 2030,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3300000,
    "researchanddevelopmenttaxcreditcarryforwardexpire": 2031,
    "deferredtaxassetstaxcreditcarryforwardsnotsubjecttoexpiration": 2000000,
    "deferredtaxassetstaxcreditcarryforwardssubjecttoexpiration": 1300000,
    "valuationallowancedeferredtaxassetchangeinamount": 30100000,
    "deferredtaxassetsvaluationallowance": 92523000,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "An uncertain tax position will not be recognized if it has less than a 50% likelihood of being sustained.",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -18821000,
    "incometaxreconciliationstateandlocalincometaxes": -7684000,
    "incometaxreconciliationtaxcreditsresearch": 3169000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": -304000,
    "incometaxreconciliationotheradjustments": -120000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 30098000,
    "deferredtaxassetsoperatinglosscarryforwards": 79230000,
    "deferredtaxassetsinprocessresearchanddevelopment": 7944000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2638000,
    "deferredtaxassetstaxdeferredexpenseoperatingleaseliabilities": 2278000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 1915000,
    "deferredtaxassetsother": 641000,
    "deferredtaxassetsgross": 94646000,
    "deferredtaxassetsnet": 2123000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": -1868000,
    "deferredtaxliabilitiesother": -255000,
    "deferredincometaxliabilities": 2123000,
    "unrecognizedtaxbenefits": 2978000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1237000
  },
  {
    "date": "2019-12-30",
    "symbol": "KURA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "DecemberÂ 31, 2019",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "KURA",
    "entityregistrantname": "KURA ONCOLOGY, INC.",
    "entitycentralindexkey": 1422143,
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-37620",
    "entitytaxidentificationnumber": "61-1547851",
    "entityaddressaddressline1": "3033 Science Park Road",
    "entityaddressaddressline2": "Suite 220",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "500-8800",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 26135000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 134499000,
    "accountsreceivablerelatedpartiescurrent": 30000,
    "prepaidexpenseandotherassetscurrent": 2682000,
    "assetscurrent": 239603000,
    "propertyplantandequipmentnet": 44000,
    "otherassetsnoncurrent": 2325000,
    "assets": 241972000,
    "accountspayableandaccruedliabilitiescurrent": 15314000,
    "longtermdebtcurrent": 250000,
    "liabilitiescurrent": 15564000,
    "longtermdebtnoncurrent": 7250000,
    "otherliabilitiesnoncurrent": 377000,
    "liabilities": 23191000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 431322000,
    "accumulatedothercomprehensiveincomelossnetoftax": 331000,
    "retainedearningsaccumulateddeficit": -212877000,
    "stockholdersequity": -212877000,
    "liabilitiesandstockholdersequity": 241972000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 45384000,
    "commonstocksharesoutstanding": 45384000,
    "researchanddevelopmentexpense": 47826000,
    "generalandadministrativeexpense": 19653000,
    "operatingexpenses": 67479000,
    "managementfeeincomerelatedparty": 200000,
    "interestandotherincome": 4674000,
    "interestexpense": 580000,
    "nonoperatingincomeexpense": 4339000,
    "netincomeloss": -63140000,
    "earningspersharebasicanddiluted": -1.51,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 41946000,
    "othercomprehensiveincomelossnetoftax": 462000,
    "comprehensiveincomenetoftax": -62678000,
    "relatedpartytransactionresearchanddevelopmentexpense": 100000,
    "relatedpartytransactiongeneralandadministrativeexpenses": 325000,
    "sharesoutstanding": 45384000,
    "stockissuedduringperiodvaluenewissues": 108129000,
    "stockissuedduringperiodsharesnewissues": 6785000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 9409000,
    "stockissuedduringperiodsharesstockoptionsexercised": 418000,
    "issuanceofcommonstockfromexerciseofoptionsandemployeestockpurchaseplan": 2936000,
    "issuanceofcommonstocksharesfromexerciseofoptionsandemployeestockpurchaseplan": 451000,
    "sharebasedcompensation": 144000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 1103000,
    "increasedecreaseinaccountsreceivablerelatedparties": -210000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1085000,
    "increasedecreaseinothernoncurrentassets": 117000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 856000,
    "increasedecreaseinothernoncurrentliabilities": 210000,
    "netcashprovidedbyusedinoperatingactivities": -54760000,
    "paymentstoacquiremarketablesecurities": 227571000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 181246000,
    "netcashprovidedbyusedininvestingactivities": -46325000,
    "proceedsfromissuanceofcommonstock": 108165000,
    "proceedsfromexerciseofstockoptionsandpurchasesunderemployeestockpurchaseplan": 2936000,
    "netcashprovidedbyusedinfinancingactivities": 111101000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 10016000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 26135000,
    "interestpaidnet": 430000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "five years",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "Lease terms may include options to extend or terminate when we are reasonably certain that the option will be exercised.",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaseoptiontoterminate": "Lease terms may include options to extend or terminate when we are reasonably certain that the option will be exercised.",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4120000,
    "operatingleaserightofuseasset": 234000,
    "operatingleaseliability": 252000,
    "cashequivalentmaturitydescription": "1 or less",
    "cashequivalentsatcarryingvalue": 18445000,
    "cashequivalentsfairvaluedisclosure": 18445000,
    "availableforsalesecuritiesmaturitydescription": "1 or less",
    "availableforsaledebtsecuritiesamortizedcostbasis": 210425000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 331000,
    "cashequivalentsandshortterminvestmentsamortizedcost": 228870000,
    "cashequivalentsandshortterminvestmentsunrealizedgains": 331000,
    "cashequivalentsandshortterminvestmentsfairvalue": 229201000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 196100000,
    "availableforsalesecuritiesdebtmaturitiesonetotwoyears": 14700000,
    "shortterminvestmentsmaturitiesdescription": "As of DecemberÂ 31, 2019, $196.1 million of our short-term investments had maturities less than one year and $14.7 million of our short-term investments had maturities between one to two years. As of December 31, 2018, all of our short-term investments had maturities less than one year.",
    "cashequivalentsandshortterminvestments": 134499000,
    "propertyplantandequipmentgross": 136000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 92000,
    "accountspayablecurrent": 3526000,
    "accruedresearchanddevelopmentexpensescurrent": 6970000,
    "employeerelatedliabilitiescurrent": 3694000,
    "otheraccruedliabilitiescurrent": 1124000,
    "debtinstrumentcarryingamount": 7500000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 33988,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.31,
    "additionalborrowingdescription": "Under the terms of the SVB Loan Agreement, we may, at our sole discretion, borrow from the Lender up to an additional $12.5 million at any time until May 1, 2020, or Term B Loan, and together with Term A Loan, the Term Loans. In addition, each Term B Loan must be in an amount equal to the lesser of $5.0 million or the amount that is remaining under the Term B Loan.",
    "debtinstrumentmaturitydate": "May 1, 2023",
    "debtinstrumentpaymentterms": "All of the Term Loans will be due on the scheduled maturity date of May 1, 2023, or Maturity Date. Repayment of the Term Loans will be interest only through NovemberÂ 30, 2020, followed by 30 equal monthly payments of principal plus accrued interest commencing on December 1, 2020.",
    "debtinstrumentnumberofequalmonthlypaymentsofprincipalandaccruedinterest": 30,
    "debtinstrumentfrequencyofperiodicpayment": "monthly",
    "debtinstrumentdateoffirstrequiredpayment1": "December 1, 2020",
    "debtinstrumentbasisspreadonvariablerate1": 0.0025,
    "debtinstrumentinterestratestatedpercentage": 0.055,
    "finalpaymentasapercentageofamountsborrowed": 0.0775,
    "debtinstrumentinterestratebasisforeffectiverate": "The per annum interest rate for any outstanding Term Loans is the greater of (i)Â 5.50% and (ii)Â the sum of (a)Â the prime rate reported in The Wall Street Journal plus (b)Â 0.25%.",
    "lineofcreditfacilityprepaymentfeepercentageonoutstandingprincipalamount": 0.02,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 669000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 3328000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 3160000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 1849000,
    "debtinstrumentfaceamount": 9006000,
    "interestpayablecurrentandnoncurrent": 1506000,
    "contingentmilestonepaid": 25000,
    "milestonepaymentspaidtodate": 300000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 300000,
    "operatingleasesrentexpensenet": 400000,
    "operatingleasecost": 503000,
    "operatingleasepayments": 485000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 472000,
    "relatedpartytransactionoperatingleaserightofuseasset": 79000,
    "operatingleaseliabilitycurrent": 156000,
    "relatedpartytransactionoperatingleasecurrentliabilities": 96000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6M",
    "operatingleaseweightedaveragediscountratepercent": 0.065,
    "increaseinpercentageofsharesofcommonstockavailableforfuturegrants": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "commonstockcapitalsharesreservedforfutureissuance": 199162,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "shareprice": 13.75,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 23000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 400000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 39543,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4080000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1948000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 636000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4080000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1882000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 16.19,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.14,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 13.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 9080000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 9080000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 7663000,
    "proceedsfromstockoptionsexercised": 2562000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4311000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.439,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.542,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.019,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.025,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 11.01,
    "stockoptionplanexpense": 9066000,
    "nonemployeesharebasedcompensationexpense": 199000,
    "employeestockpurchaseplancompensationexpense": 144000,
    "descriptionoflesseeleasingarrangementsoperatingleases": "Pursuant to the terms of the Sublease, as amended in June 2016, the Sublease would have expired on October 31, 2019. In December 2016, we entered into a third amendment to Sublease pursuant to which the Sublease expired in June 2017.",
    "relatedpartytransactionamountsreceivedonresearchanddevelopmentservices": 100000,
    "paymentofresearchanddevelopmentexpensedescription": "We have a services agreement with ALG Partners, Inc., or ALG Partners, a recruiting and temporary staffing agency. Our chief operating officer is an immediate family member of the president of ALG Partners.",
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "definedcontributionplancostrecognized": 300000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "operatinglosscarryforwards": 500000,
    "operatinglosscarryforwardsmaturitydate": 2030,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2200000,
    "researchanddevelopmenttaxcreditcarryforwardexpire": 2031,
    "deferredtaxassetstaxcreditcarryforwardsnotsubjecttoexpiration": 1500000,
    "deferredtaxassetstaxcreditcarryforwardssubjecttoexpiration": 700000,
    "valuationallowancedeferredtaxassetchangeinamount": 18800000,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "An uncertain tax position will not be recognized if it has less than a 50% likelihood of being sustained.",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -13259000,
    "incometaxreconciliationstateandlocalincometaxes": -4810000,
    "incometaxreconciliationtaxcreditsresearch": 1664000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 708000,
    "incometaxreconciliationotheradjustments": 199000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 18826000,
    "deferredtaxassetsoperatinglosscarryforwards": 53590000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4748000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2134000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 1353000,
    "deferredtaxassetsgoodwillandintangibleassets": 594000,
    "deferredtaxassetsother": 171000,
    "deferredtaxassetsgross": 62590000,
    "deferredincometaxliabilities": 165000,
    "deferredtaxassetsvaluationallowance": 62425000,
    "unrecognizedtaxbenefits": 1741000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 678000
  }
]